Retraction Note to: Alternol inhibits proliferation and induces apoptosis in mouse lymphocyte leukemia (L1210) cells (Molecular and Cellular Biochemistry, (2007), 306, 1-2, (115-122), 10.1007/s11010-007-9560-0);Alternol inhibits proliferation and induces apoptosis in mouse lymphocyte leukemia (L1210) cells

Molecular and Cellular Biochemistry

Volumn 306, Issue 1-2, 2007, Pages 115-122

  Liu, Zhao Zhe ^a   Zhu, Jin ^b,c   Sun, Bo ^b,c   Liu, Shu ^b,c   Geng, Shuo ^b,c   Liu, Xia ^b,c   Li, Chang Ling ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b INSTITUTE OF ZOOLOGY   (China)

^c UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

Alternol; Apoptosis; L1210; Leukemia

Indexed keywords

ALTERNOL; ANTINEOPLASTIC AGENT; CASPASE 3; CASPASE 8; CASPASE 9; PHOSPHATIDYLSERINE; PROTEIN BCL 2; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL MEMBRANE DEPOLARIZATION; CELL MEMBRANE POTENTIAL; CELL PROLIFERATION; CELL STRUCTURE; CELL SURVIVAL; CHROMATIN CONDENSATION; CONTROLLED STUDY; DOWN REGULATION; DRUG STRUCTURE; ENZYME ACTIVATION; LEUKEMIA CELL; LYMPHATIC LEUKEMIA; MITOCHONDRION; MOUSE; NONHUMAN; QUANTITATIVE ANALYSIS;

ALTERNARIA ALTERNATA; TAXUS;

EID: 35548953565     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-023-04899-6     Document Type: Erratum

References (38)

1. Schmidt-Wolf GD, Schmidt-Wolf IG (2003) Gene therapy for hematological malignancies. Clin Exp Med 3:4-14
2. Whiteside TL, Gooding W (2003) Immune monitoring of human gene therapy trials: Potential application to leukemia and lymphoma. Blood Cells Mol Dis 31:63-71
3. Zhang B, Wu KF, Lin YM, Ma XT, Rao Q, Zheng GG, Cao ZY, Li G, Song YH (2004) Gene transfer of pro-IL-18 and IL-1beta converting enzyme cDNA induces potent antitumor effects in L1210 cells. Leukemia 18:817-825
4. Boise LH, Gonzalez-Garcia M, Postema CE, Ding L, Lindsten T, Turka LA, Mao X, Nunez G, Thompson CB (1993) bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74:597-608
5. Chakrabarty AM (2003) Microorganisms and cancer: Quest for a therapy. J Bacteriol 185:2683-2686
6. Bhosle SM, Huilgol NG, Mishra KP (2005) Enhancement of radiation-induced oxidative stress and cytotoxicity in tumor cells by ellagic acid. Clin Chim Acta 359:89-100
7. Jabs T (1999) Reactive oxygen intermediates as mediators of programmed cell death in plants and animals. Biochem Pharmacol 57:231-45
8. Kroemer G, Reed JC (2000) Mitochondrial control of cell death. Nat Med 6:513-519
9. Cory S, Adams JM (2002) The Bcl2 family: Regulators of the cellular life-or-death switch. Nat Rev Cancer 2:647-56
10. Danial NN, Korsmeyer SJ (2004) Cell death: Critical control points. Cell 116:205-219
11. Thompson CB (1995) Apoptosis in the pathogenesis and treatment of disease. Science 267:1456-1462
12. Smets LA (1994) Programmed cell death (apoptosis) and response to anti-cancer drugs. Anticancer Drugs 5:3-9
13. Hirao A, Kong YY, Matsuoka S, Wakeham A, Ruland J, Yoshida H, Liu D, Elledge SJ, Mak TW (2000) DNA damage-induced activation of p53 by the checkpoint kinase Chk2. Science 287:1824-1827
14. Amstad PA, Liu H, Ichimiya M, Berezesky IK, Trump BF, Buhimschi IA, Gutierrez PL (2001) BCL-2 is involved in preventing oxidant-induced cell death and in decreasing oxygen radical production. Redox Rep 6:351-362
15. Dinkova-Kostova AT, Cory AH, Bozak RE, Hicks RJ, Cory JG (2007) Bis(2-hydroxybenzylidene)acetone, a potent inducer of the phase 2 response, causes apoptosis in mouse leukemia cells through a p53-independent, caspase-mediated pathway. Cancer Lett 245:341-349
16. Hollstein M, Sidransky D, Vogelstein B, Harris CC (1991) p53 mutations in human cancers. Science 253:49-53
17. Stewart ZA, Pietenpol JA (2001) p53 signaling and cell cycle checkpoints. Chem Res Toxicol 14:243-263
18. Wang X (2001) The expanding role of mitochondria in apoptosis. Genes Dev 15:2922-2933
19. Desagher S, Martinou JC (2000) Mitochondria as the central control point of apoptosis. Trends Cell Biol 10:369-377
20. Sionov RV, Haupt Y (1999) The cellular response to p53: The decision between life and death. Oncogene 18:6145-6157
21. Hou Q, Cymbalyuk E, Hsu SC, Xu M, Hsu YT (2003) Apoptosis modulatory activities of transiently expressed Bcl-2: Roles in cytochrome C release and Bax regulation. Apoptosis 8:617-629
22. Deng G, Su JH, Ivins KJ, Van Houten B, Cotman CW (1999) Bcl-2 facilitates recovery from DNA damage after oxidative stress. Exp Neurol 159:309-318
23. Chen M, Wang J (2002) Initiator caspases in apoptosis signaling pathways. Apoptosis 7:313-319
24. Wu LY, Ding AS, Zhao T, Ma ZM, Wang FZ, Fan M (2004) Involvement of increased stability of mitochondrial membrane potential and overexpression of Bcl-2 in enhanced anoxic tolerance induced by hypoxic preconditioning in cultured hypothalamic neurons. Brain Res 999:149-154
25. Farrow SN, Brown R (1996) New members of the Bcl-2 family and their protein partners. Curr Opin Genet Dev 6:45-49
26. Cohen GM (1997) Caspases: The executioners of apoptosis. Biochem J 326(Pt 1):1-16
27. van Loo G, Saelens X, van Gurp M, MacFarlane M, Martin SJ, Vandenabeele P (2002) The role of mitochondrial factors in apoptosis: A Russian roulette with more than one bullet. Cell Death Differ 9:1031-1042
28. Liu X, Kim CN, Yang J, Jemmerson R, Wang X (1996) Induction of apoptotic program in cell-free extracts: Requirement for dATP and cytochrome c. Cell 86:147-157
29. Pandey S, Smith B, Walker PR, Sikorska M (2000) Caspase-dependent and independent cell death in rat hepatoma 5123tc cells. Apoptosis 5:265-275
30. Shi Y (2002) Mechanisms of caspase activation and inhibition during apoptosis. Mol Cell 9:459-470
31. Shih CM, Wu JS, Ko WC, Wang LF, Wei YH, Liang HF, Chen YC, Chen CT (2003) Mitochondria-mediated caspase-independent apoptosis induced by cadmium in normal human lung cells. J Cell Biochem 89:335-347
32. Crompton M, Virji S, Doyle V, Johnson N, Ward JM (1999) The mitochondrial permeability transition pore. Biochem Soc Symp 66:167-179
33. Jones SP, Teshima Y, Akao M, Marban E (2003) Simvastatin attenuates oxidant-induced mitochondrial dysfunction in cardiac myocytes. Circ Res 93:697-699
34. Bhalla K, Ibrado AM, Tourkina E, Tang C, Grant S, Bullock G, Huang Y, Ponnathpur V, Mahoney ME (1993) High-dose mitoxantrone induces programmed cell death or apoptosis in human myeloid leukemia cells. Blood 82:3133-3140
35. Bhalla K, Ibrado AM, Tourkina E, Tang C, Mahoney ME, Huang Y (1993) Taxol induces internucleosomal DNA fragmentation associated with programmed cell death in human myeloid leukemia cells. Leukemia 7:563-568
36. Santos-Silva MC, Sampaio de Freitas M, Assreuy J (2001) Killing of lymphoblastic leukemia cells by nitric oxide and taxol: Involvement of NF-kappaB activity. Cancer Lett 173:53-61
37. Horwitz SB (1992) Mechanism of action of taxol. Trends Pharmacol Sci 13:134-136
38. Wahl AF, Donaldson KL, Fairchild C, Lee FY, Foster SA, Demers GW, Galloway DA (1996) Loss of normal p53 function confers sensitization to Taxol by increasing G2/M arrest and apoptosis. Nat Med 2:72-79